Feasibility Study of Anti-inflammatory Cytokines in Whole Blood in Osteoarthritis Patients
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients with evidence of osteoarthritis.
radiographic evidence of osteoarthritis
signed informed consent
< 18 years of age
blood clotting disorder or active hematologic cancer
history of rheumatoid arthritis
septic joint or fracture
active infection or history of chronic infection
use of cytokine blocking drugs with the last 6 months
intra-articular steroid or hyaluronic acid (HA) injection within last 6 months